Acorn Bioventures reported a 5% stake in enGene Therapeutics ENGN · 3,357,282 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5%
Last report: First report
Shares held: 3,357,282 sh
Class: Common Shares
Stock: enGene Therapeutics ENGN
Holder: Acorn Bioventures
Event date: 26/07/20
Filed: 26/07/22

First 5%+ report · 5% stake

enGene Therapeutics trades, last 26 weeks

What else happened in enGene Therapeutics around then

Filed or reported within 30 days of the trade day · 06/20~08/19

Acorn Bioventures's other 5% stake reports

Acorn Bioventures
5% stakeKaryopharm Therapeutics
5% stake
Karyopharm Therapeutics
KPTI
5.7% stake
1,284,221 sh
5.7% stake
Filed 09/25
Acorn Bioventures
5% stakeLeonaBio
5% stake
LeonaBio
LONA
12.1% stake
1,492,521 sh
12.1% stake
Filed 08/20
Acorn Bioventures
5% stakeKaryopharm Therapeutics
5% stake
Karyopharm Therapeutics
KPTI
6.7% stake
1,518,113 sh
6.7% stake
Filed 05/15
Acorn Bioventures
5% stakeOnKure Therapeutics
5% stake
OnKure Therapeutics
OKUR
9.5% stake
3,924,037 sh
9.5% stake
Filed 04/01
Acorn Bioventures
5% stakeJasper Therapeutics
5% stake
Jasper Therapeutics
JSPR
5.3% stake
1,486,492 sh
5.3% stake
Filed 01/26